Values Added Financial
REGN icon

Values Added Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Values Added Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$244K Buy
+322
New +$243K 0.09% 119
2026
Q2 		– Sell
-282
Closed -$218K – 151
2026
Q1 		$218K Buy
282
+3
+1% +$2.3K 0.09% 122
2025
Q4 		$215K Buy
+279
New +$189K 0.09% 125

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.22B AUM 4.07% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Values Added Financial's REGN Position: Q3 2026 in Review

Values Added Financial opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 322 shares worth $244K. The stake represents 0.09% of the portfolio and ranks #119 among its holdings. This is a return to the name: Values Added Financial previously reported a position in REGN as recently as Q1 2026.

Values Added Financial first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. 501 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Values Added Financial held 322 shares of Regeneron Pharmaceuticals worth $244K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Values Added Financial position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.09% of Values Added Financial's portfolio in Q3 2026, its #119 holding.
  • Values Added Financial first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 501 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Values Added Financial's 13F filing for Q3 2026, filed 28 Oct 2026.